Description

PT-141 (Bremelanotide) – The Neuroscientific Approach to Desire Research
A first-in-class peptide that acts centrally on the nervous system, opening new pathways for studying intimacy health.

Product Overview

PT-141 (Bremelanotide) represents a breakthrough in peptide research. Unlike conventional approaches, this synthetic melanocortin peptide targets specific brain receptors (primarily MC4R), offering researchers a unique mechanism of action for studying intimate responses.

Key Features:

Novel Mechanism: First-in-class melanocortin peptide with distinct pathway activation

Verified Purity: Comprehensive Certificate of Analysis (CoA) provided with each batch

Research Grade: Manufactured under cGMP standards in FDA-registered facilities

Multiple Formats: Available in lyophilized powder (2mg, 5mg, 10mg vials)

Technical Specifications

Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂

Molecular Formula: C₅₀H₆₈N₁₄O₁₀

Molecular Weight: 1025.2 g/mol

Purity: >99% (HPLC verified)

Formulation: Lyophilized white powder

Storage: -20°C for long-term stability

Research Applications

PT-141 is intended for scientific research purposes only, specifically:

Neuroscience studies involving melanocortin receptors

Central nervous system pathway research

Behavioral study models

Pharmacological mechanism investigations

Ordering Information

Available Sizes: 2mg, 5mg, 10mg vials

Packaging: Sealed vials with inert gas atmosphere

Shipping: Temperature-controlled global delivery

Documentation: Full COA and MSDS included

Compliance Notice
For research use only. Not for human consumption. Not for diagnostic or therapeutic use. Researchers must comply with all applicable laws and institutional guidelines.

Call to Action
Ready to advance your research?
Contact our scientific support team for:

Custom concentration requests

Bulk pricing for institutional use

Technical documentation

Protocol development assistance